61 – 70 of 802
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease
(
- Contribution to journal › Article
-
Mark
TEMRA : the CD8 subset in chronic ITP?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia : a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept study
(
- Contribution to journal › Article
-
Mark
Clonal Hematopoiesis and Risk of Incident Lung Cancer
2023) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41(7). p.1423-1433(
- Contribution to journal › Article
-
Mark
Binge-reading on immune thrombocytopenia : Everything you ever wanted to know
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Use of Linked Nordic Registries for Population Studies in Hematologic Cancers : The Case of Multiple Myeloma
(
- Contribution to journal › Article
-
Mark
Use of a recombinant deacetylase to convert A1 red blood cells to the acquired B phenotype for quality control purposes
2023) In Blood Transfusion(
- Contribution to journal › Article
-
Mark
Transfusion management in the era of magrolimab (Hu5F9-G4), an anti-CD47 monoclonal antibody therapy
(
- Contribution to journal › Scientific review
-
Mark
SID : A new carbohydrate blood group system based on a well-characterized but still mysterious antigen of great pathophysiologic interest
(
- Contribution to journal › Article
- 2022
-
Mark
The EHA Research Roadmap : Transfusion Medicine
(
- Contribution to journal › Debate/Note/Editorial